Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Plus Therapeutics Q4 EPS $(0.70) Beats $(1.07) Estimate, Sales $1.31M Beat $1.06M Estimate

Author: Benzinga Newsdesk | March 05, 2024 05:30pm
Plus Therapeutics (NASDAQ:PSTV) reported quarterly losses of $(0.70) per share which beat the analyst consensus estimate of $(1.07) by 34.58 percent. This is a 70.83 percent increase over losses of $(2.40) per share from the same period last year. The company reported quarterly sales of $1.31 million which beat the analyst consensus estimate of $1.06 million by 23.87 percent. This is a 769.54 percent increase over sales of $151.00 thousand the same period last year.

Posted In: PSTV


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist